Natalie Rainer

Subscribe to Natalie Rainer's Posts

FDA Launches Campaign on New Nutrition Facts Label

Posted on March 13, 2020

As previously covered on this blog, FDA issued final rules in May 2016 to implement changes to the nutritional labeling and serving size regulations. For manufacturers with $10 million

…
Continue Reading FDA Launches Campaign on New Nutrition Facts Label

FSANZ Releases 2019 Food Recall Statistics

Posted on February 28, 2020

Food Standards Australia New Zealand (FSANZ) has released its food recall statistics for 2019. Recalls were down from 100 in 2018 to 87 in 2019. The most common cause of

…
Continue Reading FSANZ Releases 2019 Food Recall Statistics

FDA Releases Draft Guidance on Pre-Submission Consultation Process for Animal Food Additive Petitions or Generally Recognized as Safe (GRAS) Notices

Posted on February 14, 2020

FDA Releases Draft Guidance on Pre-Submission Consultation Process for Animal Food Additive Petitions or Generally Recognized as Safe (GRAS) Notices

On February 13, 2020, the Food and Drug Administration

…
Continue Reading FDA Releases Draft Guidance on Pre-Submission Consultation Process for Animal Food Additive Petitions or Generally Recognized as Safe (GRAS) Notices

Comments on Chapter 14: Recall Plan of FDA’s Draft Guidance on Human HARPC Rule Due February 4

Posted on January 30, 2020

As previously reported on this blog, the Food and Drug Administration (FDA) has been issuing guidance chapters on compliance with its Final Rule for Preventive Controls for Human Food on

…
Continue Reading Comments on Chapter 14: Recall Plan of FDA’s Draft Guidance on Human HARPC Rule Due February 4

FSIS Publishes Updated Guidelines for “Non-GMO” Labeling Claims

Posted on January 17, 2020

On December 30, 2019, USDA’s Food Safety and Inspection Service (FSIS) published updated labeling guidelines on “Statements That Bioengineered or Genetically Modified Ingredients or Animal Feed Were Not Used in

…
Continue Reading FSIS Publishes Updated Guidelines for “Non-GMO” Labeling Claims

Bipartisan Senate Bill Would Formalize FDA-USDA Jurisdiction over Cell-Based Meat

Posted on December 20, 2019

Senators Mike Enzi (R-WY) and Jon Tester (D-MT) have introduced a bill, the “Food Safety Modernization for Innovative Technologies Act,” that would formalize the agreement between FDA and USDA

…
Continue Reading Bipartisan Senate Bill Would Formalize FDA-USDA Jurisdiction over Cell-Based Meat

California Chamber of Commerce Challenges Proposition 65 Warnings for Acrylamide

Posted on October 10, 2019

On October 7, 2019, the California Chamber of Commerce (“CalChamber”) filed suit in federal court against the California Attorney General, Xavier Becerra, to block the state from enforcing Proposition 65

…
Continue Reading California Chamber of Commerce Challenges Proposition 65 Warnings for Acrylamide

CDC Finds Decrease in Foodborne Disease Outbreaks from 2015 to 2017

Posted on October 3, 2019

The Centers for Disease Control (CDC) has released its Surveillance for Food-borne Disease Outbreaks Annual Report, which includes an analysis of all foodborne illness outbreaks reported in 2017. CDC

…
Continue Reading CDC Finds Decrease in Foodborne Disease Outbreaks from 2015 to 2017

USDA Releases Additional FAQs on Bioengineered Food Disclosure Standard

Posted on September 26, 2019

USDA’s Agricultural Marketing Service (AMS), which promulgated the National Bioengineered (BE) Food Disclosure Standard, has announced additional responses to its Frequently Asked Questions (FAQs). A total of five new FAQs

…
Continue Reading USDA Releases Additional FAQs on Bioengineered Food Disclosure Standard

Mitch McConnell Introduces Bill Amendment That Would Compel FDA to Issue CBD Enforcement Discretion Policy

Posted on September 19, 2019

Senate Majority Leader Mitch McConnell (R-KY) has introduced language into a Senate appropriations bill that would require FDA to issue temporary guidance on enforcement related to products containing cannabidiol (CBD).

…
Continue Reading Mitch McConnell Introduces Bill Amendment That Would Compel FDA to Issue CBD Enforcement Discretion Policy

The Daily Intake